These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22745701)

  • 1. A monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeys.
    Ohshima-Hosoyama S; Simmons HA; Goecks N; Joers V; Swanson CR; Bondarenko V; Velotta R; Brunner K; Wood LD; Hruban RH; Emborg ME
    PLoS One; 2012; 7(6):e39036. PubMed ID: 22745701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood-brain barrier delivery.
    Pardridge WM; Boado RJ
    Pharm Res; 2009 Oct; 26(10):2227-36. PubMed ID: 19609743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of blood-brain barrier transport of glial-derived neurotrophic factor (GDNF) and an IgG-GDNF fusion protein in the rhesus monkey.
    Boado RJ; Pardridge WM
    Drug Metab Dispos; 2009 Dec; 37(12):2299-304. PubMed ID: 19741036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin receptor antibody-iduronate 2-sulfatase fusion protein: pharmacokinetics, anti-drug antibody, and safety pharmacology in Rhesus monkeys.
    Boado RJ; Ka-Wai Hui E; Zhiqiang Lu J; Pardridge WM
    Biotechnol Bioeng; 2014 Nov; 111(11):2317-25. PubMed ID: 24889100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDNF fusion protein for targeted-drug delivery across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Wang Y; Pardridge WM
    Biotechnol Bioeng; 2008 Jun; 100(2):387-96. PubMed ID: 18080333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys.
    Su X; Kells AP; Huang EJ; Lee HS; Hadaczek P; Beyer J; Bringas J; Pivirotto P; Penticuff J; Eberling J; Federoff HJ; Forsayeth J; Bankiewicz KS
    Hum Gene Ther; 2009 Dec; 20(12):1627-40. PubMed ID: 19671001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very High Plasma Concentrations of a Monoclonal Antibody against the Human Insulin Receptor Are Produced by Subcutaneous Injection in the Rhesus Monkey.
    Boado RJ; Hui EK; Lu JZ; Pardridge WM
    Mol Pharm; 2016 Sep; 13(9):3241-6. PubMed ID: 27513815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood-brain barrier.
    Fu A; Zhou QH; Hui EK; Lu JZ; Boado RJ; Pardridge WM
    Brain Res; 2010 Sep; 1352():208-13. PubMed ID: 20599807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys.
    Zhang Z; Miyoshi Y; Lapchak PA; Collins F; Hilt D; Lebel C; Kryscio R; Gash DM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1396-401. PubMed ID: 9316852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological effects of intraputaminal infusion of glial cell line-derived neurotrophic factor in Parkinson disease model macaque monkeys.
    Oiwa Y; Nakai K; Itakura T
    Neurol Med Chir (Tokyo); 2006 Jun; 46(6):267-75; discussion 275-6. PubMed ID: 16794346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
    Hoban DB; Howard L; Dowd E
    Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new generation of neurobiological drugs engineered to overcome the challenges of brain drug delivery.
    Boado RJ
    Drug News Perspect; 2008 Nov; 21(9):489-503. PubMed ID: 19180267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG-single chain Fv fusion protein therapeutic for Alzheimer's disease: Expression in CHO cells and pharmacokinetics and brain delivery in the rhesus monkey.
    Boado RJ; Lu JZ; Hui EK; Pardridge WM
    Biotechnol Bioeng; 2010 Feb; 105(3):627-35. PubMed ID: 19816967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein.
    Boado RJ; Hui EK; Lu JZ; Zhou QH; Pardridge WM
    J Biotechnol; 2010 Mar; 146(1-2):84-91. PubMed ID: 20100527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody-glial-derived neurotrophic factor fusion protein penetrates the blood-brain barrier in the mouse.
    Zhou QH; Boado RJ; Lu JZ; Hui EK; Pardridge WM
    Drug Metab Dispos; 2010 Apr; 38(4):566-72. PubMed ID: 20075191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody-Iduronidase Fusion Protein.
    Boado RJ; Pardridge WM
    Mol Pharm; 2017 Apr; 14(4):1271-1277. PubMed ID: 28279069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin Receptor Antibody-α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts.
    Boado RJ; Lu JZ; Hui EK; Lin H; Pardridge WM
    Mol Pharm; 2016 Apr; 13(4):1385-92. PubMed ID: 26910785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier molecular trojan horse enables imaging of brain uptake of radioiodinated recombinant protein in the rhesus monkey.
    Boado RJ; Hui EK; Lu JZ; Sumbria RK; Pardridge WM
    Bioconjug Chem; 2013 Oct; 24(10):1741-9. PubMed ID: 24059813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
    Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
    Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.
    Kordower JH; Emborg ME; Bloch J; Ma SY; Chu Y; Leventhal L; McBride J; Chen EY; Palfi S; Roitberg BZ; Brown WD; Holden JE; Pyzalski R; Taylor MD; Carvey P; Ling Z; Trono D; Hantraye P; Déglon N; Aebischer P
    Science; 2000 Oct; 290(5492):767-73. PubMed ID: 11052933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.